Technical Analysis for PCRX - Pacira Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade B 43.33 0.00% 0.00
PCRX closed unchanged on Friday, May 24, 2019, on 65 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Its advance stalled at its 200 day moving average, an important long-term support / resistance line. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Flat Up Down
See historical PCRX trend table...

Date Alert Name Type % Chg
200 DMA Resistance Bearish 0.00%
Stochastic Buy Signal Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Oversold Stochastic Weakness 0.00%
200 DMA Resistance Bearish 0.00%
Oversold Stochastic Weakness 0.00%
Fell Below 200 DMA Bearish -0.30%
Stochastic Reached Oversold Weakness -0.30%
Oversold Stochastic Weakness -0.30%

Older signals for PCRX ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Pacira Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, commercializes, and manufactures pharmaceutical products for use in hospitals and ambulatory surgery centers worldwide. It develops pharmaceutical products based on its proprietary DepoFoam drug delivery technology. The company markets EXPAREL, a liposome injection of bupivacaine, an amide-type local anesthetic, indicated for administration into the surgical site to produce postsurgical analgesia; and DepoCyt(e), a liposomal formulation of the chemotherapeutic agent cytarabine indicated for the intrathecal treatment of lymphomatous meningitis, a cancer of the immune system. Its product pipeline comprise EXPAREL that has completed Phase II clinical trials for postsurgical analgesia-nerve block administration; DepoNSAID, which is in preclinical trials for the relief of acute pain; and DepoMethotrexate that is in preclinical trials for the treatment of rheumatoid arthritis and oncology, as well as Bupivacaine Liposome Injectable Suspension for veterinary postsurgical analgesia. Pacira Pharmaceuticals, Inc. has a development and commercialization agreement, and related supply agreement with Aratana Therapeutics, Inc. The company was formerly known as Pacira, Inc. and changed its name to Pacira Pharmaceuticals, Inc. in October 2010. Pacira Pharmaceuticals, Inc. was founded in 2006 and is headquartered in Parsippany, New Jersey.
Medicine Health Cancer Pharmaceutical Pain Surgery Pharmaceutical Products Pharmaceutical Industry In China Pharmacology Rheumatoid Arthritis Dosage Forms Piperidines Drug Delivery Technology Bupivacaine Liposome Surgical Site
Is PCRX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 55.0
52 Week Low 30.0
Average Volume 574,723
200-Day Moving Average 43.4488
50-Day Moving Average 41.206
20-Day Moving Average 44.9675
10-Day Moving Average 44.457
Average True Range 1.6327
ADX 24.97
+DI 24.1757
-DI 21.2981
Chandelier Exit (Long, 3 ATRs ) 44.6019
Chandelier Exit (Short, 3 ATRs ) 43.9981
Upper Bollinger Band 49.5716
Lower Bollinger Band 40.3634
Percent B (%b) 0.32
BandWidth 20.477456
MACD Line 0.6811
MACD Signal Line 1.229
MACD Histogram -0.5479
Fundamentals Value
Market Cap 1.75 Billion
Num Shares 40.4 Million
EPS -1.72
Price-to-Earnings (P/E) Ratio -25.19
Price-to-Sales 4.67
Price-to-Book 5.03
PEG Ratio -3.43
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 44.49
Resistance 3 (R3) 44.59 44.31 44.29
Resistance 2 (R2) 44.31 44.02 44.26 44.23
Resistance 1 (R1) 43.82 43.83 43.68 43.72 44.16
Pivot Point 43.54 43.54 43.47 43.49 43.54
Support 1 (S1) 43.05 43.25 42.91 42.95 42.50
Support 2 (S2) 42.77 43.06 42.72 42.43
Support 3 (S3) 42.28 42.77 42.37
Support 4 (S4) 42.18